Olcucu et al. [44] categorized 99 TGCT patients into two groups of NLR < 3.219 and ≥ 3.219 and compared them in terms of conventional tumor markers (AFP, B-HCG, and LDH). The gene discussed is AFP; the disease is neoplasm.